Type B Aortic Dissection Quality Control Platform

Inclusion criteria

• Aged between 18 and 80 years (inclusive);
• Definite diagnosis of Stanford type B aortic dissection confirmed by three-dimensional CTA reconstruction;
• Underwent TEVAR, including standalone TEVAR and hybrid procedures (only non-thoracotomy hybrid procedures);
• Patients and their families signed informed consent and agreed to complete the 2-year full follow-up.

Exclusion criteria

• Presence of severe comorbidities or other diseases (e.g., severe chronic obstructive pulmonary disease, malignant tumors, dementia) or any physical condition that may affect patient compliance with this study;
• A previous history of thoracic aortic surgery (including TEVAR, hybrid surgery, and open surgery);
• Congenital aortic malformations;
• Requiring concurrent intervention for cardiac or aortic sinus root lesions, or cardiac diseases that would alter the postoperative medication regimen;
• Pregnant or breastfeeding women;
• Complicated with Stanford type A intramural hematoma, supra-aortic vessel occlusion, or refusal of relevant repair;
• A history of stroke or acute myocardial infarction within 30 days prior to surgery;
• Receipt of any major surgical or interventional procedures within 30 days prior to surgery;
• Scheduled to undergo any major elective surgical or interventional procedures within 30 days after index surgery;
• Participation in other ongoing drug or device trials with unmet primary study endpoints.